3.055USD+1.48%Mkt Cap: 13.92M USDP/E: —Last update: 2026-06-01
Lunai Bioworks Inc., a pre-clinical stage biotechnology company, provides medicine, diagnostics, and biodefense products the United States and the Netherlands. It operates through three segments, RENB, BioSymetrics, and …
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap13.92M USD
Enterprise Value12.22M USD
Revenue (TTM)20.94K USD
Gross Profit20.94K USD
Net Income (TTM)-178.01M USD
Revenue/Share0.0080 USD
Last Price3.055 USD
Fiscal Year EndJun 2025
MR QuarterMar 2026
Employees29
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-1.25
EV/Revenue583.54
P/S666.81
P/B-5.50
EPS (TTM)-61.52
EPS (Forward)—
52W Range
1.2085% of range36.00
52W High36.00 USD
52W Low1.208 USD
Profitability
Gross Margin100.00%
Oper. Margin-6815.30%
EBITDA Margin0.00%
Profit Margin0.00%
ROE833.76%
ROA-2162.69%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-7.87M USD
CapEx (TTM)—
FCF Margin-33254.71%
FCF Yield-50.03%
Net Debt-1.74M USD
Net Debt/EBITDA0.18
Balance Sheet
Debt/Equity-0.48
Current Ratio0.19
Quick Ratio0.16
Book Value/Sh-0.5600 USD
Cash/Share0.6960 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:8
Split DateMay 22, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.4.53M
Float3.35M
Insiders31.30%
Institutions2.76%
Short Interest
Short Ratio0.3d
Short % Float7.87%
Short % Out.6.86%
Shares Short311.20K
Short (prev mo.)97.45K
Technical
SMA 502.728 (+12.0%)
SMA 2007.741 (-60.5%)
Beta0.33
S&P 52W Chg27.94%
Avg Vol (30d)769.26K
Avg Vol (10d)204.69K
Technical Indicators
RSI (14)60.3
MACD-0.0272
MACD Signal-0.1317
MACD Hist.+0.1045
BB Upper3.034 USD
BB Middle2.416 USD
BB Lower1.797 USD
BB Width51.19%
ATR (14)0.3848 USD
Vol Ratio (20d)0.11x